TIMOTHY BOOKER: Open Payments
NPI 1538494091 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,934 in 100 payments from 18 companies in 2025. Trend: 2023 $2,720 · 2024 $2,598 · 2025 $1,934
Food & beverage: $1,934
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $447 |
| Novartis Pharmaceuticals Corporation | 21 | $428 |
| PFIZER INC. | 20 | $340 |
| SK Life Science, Inc. | 7 | $140 |
| UCB, Inc. | 6 | $97 |
| Amgen Inc. | 4 | $87 |
| Biogen, Inc. | 4 | $77 |
| Neurocrine BioSciences, Inc. | 3 | $49 |
| Lundbeck LLC | 2 | $48 |
| Axsome Therapeutics, Inc. | 2 | $33 |
Products named: KESIMPTA, NURTEC ODT, QULIPTA, UBRELVY, UPLIZNA, Briviact, INGREZZA, VYEPTI.
Industry payments across AR — which companies pay providers there.
